Botulinum toxin type A (Botox, Dysport) blocks the release of a neurotransmitter known as acetylcholine from nerve cells. Acetylcholine normally transmits nerve impulses to muscle cells, causing them to contract. Without acetylcholine, the affected nerve is unable to send a signal to the muscle it supplies, resulting in a weakened or paralysed muscle. The effect of Botox injections is restricted to the area being treated.
This module has been specifically designed to enable appropriate health professionals to undertake injection therapy using botulinum toxin for the management of patients/clients with limb spasticity or dystonia regardless of the form of botulinum toxin used in their trust. Learners will be supported in developing their skills and techniques in clinical reasoning, injection administration and after care to provide a comprehensive management approach.
The module aims to introduce students to the theory and practice of injection therapy as well as to develop their ability to clinically reason and integrate the use of injection therapy as part of their management of patients/clients with neurological dysfunction. The module consists of two main components. The first component will introduce students to the theory and practice associated with the use of injection therapy and the second component will be a period of mentored practice in the clinical environment.
Who is this module for?
Suitable for physiotherapists and other relevant healthcare professionals.
Programme entry requirements
In addition, written confirmation will be needed from:
• The employer/Trust showing their support for the participant to undertake the module.
• Designated medical practitioners (DMP) who meets eligibility criteria for medical supervision and who has agreed to provide the required term of supervised practice.
Objective structured physical examination (OSPE) and portfolio